跳至主要内容
临床试验/NCT01237964
NCT01237964Unknown2 期

Phase 2 Of Injectable Collagenase (Xiaflex) For Burns' Associated Contracture

Sheba Medical Center1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2011年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
10
试验地点
1
主要终点
Increase functionality of involved joint

研究概览

简要总结

A pilot experiment to test the efficiency of the enzyme Collagenase in treating contractures which result's from burn's healing process.

So far, treatment of choice in patients with burn's created movement limiting contractures, concentrated around supportive care. Patients were referred to surgical intervention only if necessary. Treatment by injecting an external enzyme is avant-garde and hasn't been done under such conditions.

This study might introduce a new kind of treatment, which can be done in ambulatory environment .This type of treatment might significantly improve patients' function and quality of life, with no need for a surgical intervention.

详细描述

Scientific Background:

Contracture is defined as a scar tissue that replaces the original tissue and leads to shortening and tightening of the muscle results in a range of motion limitation and deformity. Contracture creation is common in burn's healing process. The process itself involves fibrosis of the effected area including intrusion towards the deep layers of the skin, and can be described as ineffective healing process. In many cases these scars have major functional and cosmetic implications that challenges the plastic surgery departments around the world.

Creation of bands, webs and contractures close to a joint area can cause a significant movement limitation and shortens the range of motion. Until recently, failure of treatment with bandaging, splints and physiotherapy activity usually led to surgical intervention involving many kinds of techniques ranging from simple incisions, Z-Plasties to skin grafts, and flaps. All these methods were meant to release the contracture itself and restore the functional capability.

A recent study showed that it's possible to use the collagenase enzyme in releasing dupuytren's contracture by a simple injection, a procedure that can be preformed under ambulatory conditions. This kind of contracture causes a fixed flexion of the fingers towards the palm of the hand. The study was a double blinded, placebo controlled study and involved 308 patients, all suffered from contracture with at least 20 degrees range of movement limitation. In the end, it was proved beyond any doubt that collagenase is effective in releasing and restoring range of motion of dupuytren's contracture. These positive results might indicate the possibility of using collagenase in other kinds of contractures.

In this study the investigators intend to perform a preliminary test of the effectiveness of collagenase in treating contracture that developed due to the burn's healing process. As comparison parameters the investigators will compare the range of motion before and after treatment and subjective feeling of pain (again, before and after treatment) according to VAS scale of pain. Also the investigators will try to monitor any kind of side effects that might appear.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Contracture is 6 month old or more
  • Place of contracture in a flex-ext joint only (e.g knee, elbow)
  • Contracture leads to 15% decrease in joint range of movement vs anatomical range
  • Physiotherapy can no longer improve those patients condition

排除标准

  • Any systemic condition involving skin or soft tissue disease
  • skin disease related to elastin, collagen or keratinocytes
  • Known allergy to Clostridium Collagenase enzyme
  • Psychiatric, Prisoners, Soldiers, Pregnant women
  • Patients whom due to their home location will not be available to frequent surveillance

研究组 & 干预措施

Xiaflex ( Collagenase use)

Experimental

all 10 patients will be selected from out burn's clinic pool and will be injected using collagenase

干预措施: Xiaflex (FDA approved collagenase) (Drug)

结局指标

主要结局

Increase functionality of involved joint

时间窗: 28 days after injection

range of motion of the joint involved will be measured using Goniometer

Pain assessment

时间窗: 28 days after injection

will be measured using VAS pain scale

次要结局

未报告次要终点

研究者

申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验

Injectable Collagenase For Burns' Associated... | 临床试验